![Matthew Norton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Norton
Directeur/Membre du Conseil chez
LGC Ltd.
Profil
Matthew R.
Norton is currently a Non-Executive Director at LGC Ltd. since 2020, a Non Executive Director at BioAgilytix Labs LLC since 2021, and a General Partner at Ampersand Management LLC starting in 2025.
Former roles include Non Executive Director at STADA Arzneimittel AG, Director at Medpace, Inc. from 2015 to 2017, Independent Director at Medpace Holdings, Inc. from 2015 to 2017, Director at Advanz Pharma Services (UK) Ltd., and Partner at Cinven Group Ltd. Education includes a graduate degree from Imperial College London conferred in 2007.
Postes actifs de Matthew Norton
| Sociétés | Poste | Début |
|---|---|---|
LGC Ltd.
 LGC Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences measurement and tools company | Directeur/Membre du Conseil | 01/01/2020 |
BioAgilytix Labs LLC
 BioAgilytix Labs LLC Miscellaneous Commercial ServicesCommercial Services Operates as a bioanalytical laboratory for testing of new therapies to all phases of drug development for pharmaceutical and biotechnology organizations | Directeur/Membre du Conseil | 01/12/2021 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Private Equity Investor | 03/09/2025 |
Anciens postes connus de Matthew Norton
| Sociétés | Poste | Fin |
|---|---|---|
| MEDPACE HOLDINGS, INC. | Directeur/Membre du Conseil | 15/06/2017 |
Medpace, Inc.
 Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to the pharmaceutical, biotech and medical industries | Directeur/Membre du Conseil | 01/01/2017 |
| STADA ARZNEIMITTEL | Directeur/Membre du Conseil | - |
Advanz Pharma Services (UK) Ltd.
 Advanz Pharma Services (UK) Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and consumer health products | Directeur/Membre du Conseil | - |
Cinven Group Ltd.
 Cinven Group Ltd. Investment ManagersFinance Cinven Group seeks investment opportunities in companies located in Europe and the United States. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Private Equity Investor | - |
Formation de Matthew Norton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: GenericHealth Technology Manufactures generic drugs and pharmaceuticals | Health Technology |
Cinven Group Ltd.
Cinven Group Ltd. Investment ManagersFinance Cinven Group seeks investment opportunities in companies located in Europe and the United States. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LGC Ltd.
LGC Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences measurement and tools company | Commercial Services |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to the pharmaceutical, biotech and medical industries | Commercial Services |
Medpace Holdings, Inc.
 Medpace Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a a clinical contract research organization company which provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries | Commercial Services |
Advanz Pharma Services (UK) Ltd.
Advanz Pharma Services (UK) Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and consumer health products | Health Technology |
BioAgilytix Labs LLC
BioAgilytix Labs LLC Miscellaneous Commercial ServicesCommercial Services Operates as a bioanalytical laboratory for testing of new therapies to all phases of drug development for pharmaceutical and biotechnology organizations | Commercial Services |
